News & Analysis as of

Life Sciences Financing Initial Public Offering (IPO)

Fenwick & West Life Sciences Group

The Most-Funded Year Ever for Digital Health Startups – New Trends, Opportunities Emerge in Q3

At the end of Q3, aggregate funding raised by digital health startups in 2021 surpassed $20 billion. Although 2021 continues to be a record-breaking year for digital health startups, investors gently tapped the breaks in Q3....more

Rothwell, Figg, Ernst & Manbeck, P.C.

Caribou Biosciences Raises $304M in Potentially the Largest Gene Editing IPO

Caribou Biosciences, Inc., a Berkeley, California-based CRISPR genome-editing biopharmaceutical company, raised $304M in an initial public offering, one of the most lucrative IPOs in gene-editing. In June 2021, Gene editing...more

Orrick, Herrington & Sutcliffe LLP

Life Sciences Snapshot: A Quarterly Report on Financing Trends - Companies & Investors Navigate the Pandemic Era Q2 2020

In this edition of Orrick’s series of life sciences publications, we offer a market update drawing on a variety of PitchBook datasets depicting macro trends in financing across the market, as well as a spotlight on any trends...more

Fenwick & West LLP

Key Metrics for Recent Technology and Life Sciences Initial Public Offerings

Fenwick & West LLP on

In this Newsletter: - Survey Results - Offerings Completed - Size of Offerings, Red Herring Midpoint - Size of Offerings, Final IPO Price - Aggregate Amount Raised, Red Herring Midpoint ...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide